MUNICH, Germany (Reuters) -The CEO of German medical technology firm Brainlab said on Tuesday that geopolitical uncertainties had prompted the decision to put on hold its planned initial public offering, adding that business in the last quarter looked positive.
“We have to recognise that the current geopolitical uncertainties continue to have a significant impact on the international capital markets,” wrote Rainer Birkenbach in an internal memo seen by Reuters, adding that at this time, an IPO did not offer optimal conditions for the company.
(Reporting by Alexander HuebnerWriting by Madeline ChambersEditing by Miranda Murray)
Comments